510(k) K253048
K253048 is an FDA 510(k) premarket notification submitted by Shenzhen Maiwei Biotech Co., Ltd. for the device "High Pressure Syringe; Pressure Connecting Tube; Quick fill tube; Spike; Transfer Tube". The FDA issued a decision of Substantially Equivalent on April 16, 2026. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- April 16, 2026
- Date Received
- September 22, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Injector And Syringe, Angiographic
- Device Class
- Class II
- Regulation Number
- 870.1650
- Review Panel
- HO
- Submission Type